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ABSTRACT. Carbazoles and imidazole represent two important classes of heterocycles which exhibit diverse 
biological activities such as antitumor properties. In this study, imidazole (C1-C3) and carbazole (C4 and C5) 
derivatives were evaluated for their cytotoxic activity against three human cancer cell lines namely, MCF7 
(human breast cancer), HT29 (human colon cancer), and HeLa (human cervical cancer). Carbazole derivatives 
(C4 and C5) with IC50 < 10 µM showed greater cytotoxic effect than imidazole derivatives (C1-C3). Furthermore, 
all compounds exhibited better anticancer activity against MCF-7 than other two cell lines (HT-29, HeLa) and 
compound C4 was the most potent compound with the IC50 values of 2.5, 5.4 and 4.0 µM, against MCF-7, Hela 
and HT-29 cell lines, respectively. Physicochemical properties of compounds were calculated and their correlation 
with the IC50 values on MCF-7 cell line investigated. Surface area and polarizability of compounds showed good 
correlation by R2 = 0.8396 and R2 = 0.834, respectively. Docking studies of these compounds were also performed 
on the DNA as proposed target to comprehend their binding interactions and binding energies. The docking 
energy of compounds ranged from - 11.32 to -13.48 kcal/mol. Compound C3 with energy of -13.48 kcal/mol had 
the highest docking energy. Docking results indicated that these compounds (C1-C5) had strong affinity in 
binding to the DNA. 
  




Cancer after the cardiovascular problems is one of the most spread and mortal disease in the 
world. Hence, the development of new and potent anticancer agents, is one of the fundamental 
goals in the medicinal chemistry [1]. 
Carbazole heterocyclic ring is a major constituent of many natural alkaloids and synthetic 
derivatives, possessing variant biological activities [2]. These activities including anticancer [3], 
anti-inflammatory and analgesic effects. Fujita et al. [4] reported that the carbazole derivatives, 
NP-10, NP-14 and HND-007, exhibit significant anticancer activity as a novel anti-microtubule 
agents (Figure 1). Moreover, Kamble and co-worker synthesized carbazoles derivatives which 
indicate partial anticancer and significant antitubercular activities [2]. In addition to these 
reports, Lansiaux et al. synthesized and screened novel carbazole derivatives for cytotoxic along 
with topoisomerase II inhibitory activities which the best compound (53) displayed a high 
cytotoxicity (IC50 = 150 nM), higher than etoposid (IC50 = 490 nM) (Figure 1) [5]. 
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Figure 1.  Chemical structures of NP-10, HND-007, NP-14 and 53. 
 
It is well known that imidazole heterocyclic nucleus is main part of many therapeutic agents 
with antifungal (econazole, miconazole, metranidazole, ketoconazole and itraconazole), and 
anticancer (dacarbazine, azathioprine and zoledronic acid) activity [6]. The importance of this 
nucleus has drawn attention of researchers to synthesize and develop new agents bearing 
imidazole ring. For example, Yurttas et al. synthesized new imidazole derivatives and evaluated 
their cytotoxicity against 60 human tumor cell lines along with antimicrobial and antifungal 
activities [7]. Furthermore, Salerno and co-workers designed and synthesized novel imidazole 
derivatives based on azalanstat and investigated their antiproliferative properties in prostate 
((DU-145, PC3, LnCap) and breast cancer cell lines (MDA-MB-231, and MCF-7) [8].  
Based on these premises and importance of imidazole and carbazole heterocyclic nucleuses 
in medicinal chemistry, we investigated imidazole and carbazole derivatives, which were 
synthesized recently [9-11], for cytotoxic activity.  
Physicochemical properties of compounds, to indicate their correlation with the IC50 values 
on MCF-7 cell line, were calculated. Docking study of these compounds was also carried out to 






All cell lines were purchased from Pasteur Institute of Iran (Tehran, Iran). RPMI-1640 and 
DMEM medium were purchased from Sigma Aldrich. Fetal bovine serum (FBS) and L-
glutamine, were purchased from Gibco Invitrogen Co. (Scotland, UK). Dimethyl sulfoxide 
(DMSO), doxorubicin (DOX), penicillin, streptomycin and sulforhodamine B (SRB) were 
purchased from Sigma Chemical Co. (Saint Louis, USA). 
 
Cell cultures and MTT assay 
 
The cytotoxic activity of five carbazole and imidazole derivatives were evaluated using a 3-(4, 
5-dimethylthiazol-2-y -2,5-diphenyl tetrazolium bromide (MTT) assay. In briefly, for the assay, 
three cell lines (MCF-7, HT-29 and HeLa) were freshly isolated and seeded in 96-well flat 
bottom tissue culture plate at a concentration of 1×105 cells/well containing 100 μL of RPMI-
1640 (supplemented with 10% FBS) tissue culture medium. Then the microplate was incubated 
in incubator at 37 °C for 24 h. After discarding the medium, 100 μL of compounds with 
different concentration (0.1, 1, 10, 25, 50 75, 100 μM) were added to each deep plate. The plates 
were incubated for 48 h. After incubation, 100 μL of the supernatant media was removed and 
100 μL of MTT solution (0.5 mg/mL) added and incubated at 37 °C for 3h. After the incubation, 
the MTT solution was discarded and 80 µL of DMSO was added to dissolve formazan. The 
optical density was determined at 540 nm using an ELISA plate reader (Bio-Tek, Winooski, VT, 
USA). The cell growth inhibition was calculated based on the following expression: 
% Cell Viability =
                       
                            
 ×100                                  (1) 
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% Cell Inhibition = 100 - % Cell Viability                                    (2) 
IC50 value was calculated by extrapolating a graph with % cell inhibition on Y-axis against 
concentration of test compound on X-axis. 
 
Statistical analysis  
 
The IC50 values were calculated using Curve Expert 1.4. and were expressed as mean ± SD. 
One-way analysis of variance (ANOVA) were used for analysis of MTT cytotoxicity results and  




Physicochemical properties of compounds including SA (surface area),  volume, HE (hydration 
energy), Log P, polariability, reflectivity and mass, after minimizing of energy based on two 
methods (molecular mechanic (MM+) and semiempirical (AM1) were calculated using 




The docking studies were performed using an in house batch script (DOCKFACE) [12-16] of 
AutoDock 4.2. HyperChem 8 was applied to optimized energy of each ligand with MM+ and 
AM1 minimization methods. Then the partial charges of atoms were calculated using Gasteiger-
Marsili procedure. Non-polar hydrogens of compounds were merged and then rotatable bonds 
were assigned. Then mol2 format was converted PDBQT by MGL tools 1.5.6 [17].  
The 3D crystal structure of DNA (PDB ID: 1BNA) as potential targets for our compounds 
were retrieved from protein data bank (http://www.rcsb.org/pdb/home/home.do). After 
removing water molecules, missing hydrogens were added and non-polar hydrogens were 
merged into their corresponding carbons using AutoDock Tools [18]. As search algorithms, 
Lamarckian Genetic Algorithm (LGA) was applied and performed by AutoDock 4.2. [17, 19-
21]. Finally, the PDBQT file of the receptors was obtained using MGLTOOLS 1.5.6. 
For Lamarckian GA, a maximum number of 2,500,000 energy evaluations, 27,000 
maximum generations; 150 population sizes, a gene mutation rate of 0.02; and a crossover rate 
of 0.8 were applied. The grid maps of the receptors were calculated using AutoGrid tools of 
AutoDock 4.2. The grid box parameters for these targets were shown in the Table 1. The grid 
box parameters of 1BNA were 60×74×120 points in x, y, and z directions. gpf and dpf as grid 
and docking parameter files were built by AutoDock Tools. 
 
Table 1. Gridbox parameters in AutoDock 4.2. 
 
Parameter Name DNA 
PDB ID 1BNA 
Grid spacing 0.375 
Box X center 15.81 
Box Y center 21.31 
Box Z center 9.88 
 
RESULTS AND DISCUSSION 
In vitro cytotoxicity 
 
In this study, all heterocyclic compounds were evaluated against three cell lines including MCF-
7, HT-29 and HeLa by standard MTT assay method (Table 2). 
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Table 2. Chemical structure of the compounds C1-C5 and their IC50 values. 
 
 
Comparison between these compounds on MCF-7 cell line indicated that after standard drug 
(doxorubicin), compound C4 had better cytotoxic effect with IC50=2.50 µM. 
As shown above, carbazole derivatives, compounds namely: C4 and C5 with IC50 < 10 µM 
showed greater cytotoxic effect than imidazole derivatives (C1-C3). Furthermore, all 
compounds exhibited better anticancer activity against MCF-7 than other two cell lines (HT-29, 
HeLa). The order of the cytotoxic effect of the compounds on different cell lines is as follows: 
MCF7 cell line: DOX > C4 > C5 > C1 > C2 > C3; HT-29 cell line: DOX > C4 > C5 > C3 > C2 
> C1 and HeLa cell line: DOX > C4 >C 5 > C1 >C2 > C3.   
Compound C4 was the most potent compound against all cell lines MCF-7, Hela and HT-29 
with the IC50 values 2.5, 5.36 and 4.03 µM, respectively. As shown in Table 2, among 
compounds C1-C3 as imidazole derivatives, compound C1 with IC50 28.7 and 6.63 µM against 
MCF-7 and Hela, respectively, showed significant anticancer activity than C2 and C3. 
As mentioned above, imidazole and carbazole derivatives have attracted considerable 
attention because of variable biological activity such as anticancer activity. Thus, selected 
compounds which bearing imidazole and carbazole rings, were subjected to MTT assay and 
structure-activity relationship (SAR) of compounds was investigated. Comparison between 
carbazole derivatives C2 and C3, which contain NO2 and NH2 substitution, respectively, 
indicated that the NO2 group had a greater effect on cytotoxic activity against MCF-7 cell line 
than NH2 group.  
Compound C4 and C5, similar to imidazole derivatives C2 and C3, showed that NO2 group 
had higher anticancer effect than NH2 group against all tested cell lines. Overall, all compounds 
have no significant effect against HT-29 cell line and none of them shown more cytotoxic effect 
than doxorubicin as positive control. 
Carbazole derivatives (C4 and C5) showed higher cytotoxic activity against MCF-7 cell line 
in comparison to the other anticancer agents such as imidazolylphenylheterocyclic-2-
 




 ± SD) μM 
MCF-7 HeLa HT-29 
C1 
 
28.7 ± 4.1 39.6 ± 8.3 >100 
C2 
 
48.3 ± 4.1 >100 >100 
C3 
  
75.3 ± 12.4 >100 76.8 ± 15.5 
C4  2.5 ± 1.2 5.4 ±1.3 4.0 ± 0.9 
C5  8.2 ± 3.7 6.6 ± 2.8 4.5 ± 1.3 
Doxorubicin - 1.4 ± 0.3 0.9 ± 0.2 0.7 ± 0.2 
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ylmethylenethiazole-2-amine derivatives [22]. Furthermore, compound C4 and C5, had more 
cytotoxic activity on HeLa cell line than most of hybrid compounds of imidazole scaffold-based 
2-benzylbenzofuran and carbazole alkaloide [23]. In addition,these compounds are effective on 
the greater number of cell lines than those mentioned above [22, 24], which showed the broader 




Physicochemical properties of compounds including surface area, volume, hydration energy, 
Log P, polariability, reflectivity and mass are presented in Table 3.  
 






Log P Polarizability Reflectivity Mass 
C1 874 1531 -8.41 6.65 62.99 159 522 
C2 1105 1973 -18.51 11.1 80.31 210 824 
C3 1083 1921 -16.98 9.67 79.33 204 764 
C4 800 1430 -16.72 8.76 59.71 153 539 




Figure 2. A plot of IC50 values on MCF-7 cell line against A) surface area and B) polarizability. 
Surface area and polarizability of compounds showed good correlation with IC50 
values on MCF-7 cell line by R2 = 0.8396 and R2 = 0.834, respectively. 
 
The IC50 values on MCF-7 cell line and physicochemical properties of compounds were 
plotted and the results showed that surface area and polarizability had good correlation than the 
other physicochemical properties. 
The IC50 values on MCF-7 cell line showed good correlation with surface area and 
polarizability of compounds by R2 = 0.8396 and R2 = 0.834, respectively. The other 
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Table 4. Docking binding energy (kcal/mol) of DNA (1BNA) by AutoDock 4.2. 
 









Figure 3. Interaction of compound 3 with DNA (1BNA). The amino groups of compound 3 were 
involved in hydrogen bonds with Adenosine 6 and Guanosine 4 of DNA. There was 
also exists an aren-H interaction between the imidazole ring and adenosine 5 of DNA. 
Furthermore, 3D interactions of compound C3 into minor groove of DNA was shown in the 
Figure 3. The amino groups of compound C3 were involved in hydrogen bond interactions with 
adenosine 6 and guanosine 4. There was also exists an aren-H interaction between the imidazole 
ring and adenosine 5 of DNA. 
Docking studies of these compounds were also performed on the DNA as proposed targets 
to found out their binding interactions and binding energies. Based on molecular docking 
results, it can be concluded that these compounds had stronger affinity to bound with DNA and 
compound C3 with energy of -13.48 kcal/mol had the highest affinity to bound with this target. 
CONCLUSIONS 
In the present work, the cytotoxic activity of the five imidazole and carbazole compounds were 
evaluated using MTT test on three cell lines namely breast cancer (MCF-7), cervical cancer 
(HeLa) and colon cancer (HT-29). The most cytotoxic activity in the entire set was related to 
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carbazole derivative, compound C4. Based on these results, carbazole derivatives had better 
cytotoxic effects than imidazole derivatives and nitro substituted groups showed more cytotoxic 
activity than amino substituted groups. The docking simulations were carried out by means of 
AutoDock 4.2. to find the best pose of each ligand in the active site of the DNA and tubulin as 
proposed targets. Base on the docking binding energies, these compounds had stronger affinity 
in binding to the DNA, and the compound C3 had the highest docking energy when docked into 
the DNA. Although the molecular weight of these compounds is more than 500, biological 
results show that these compounds have acceptable anti-cancer effects. The range below 500 is 
one of Lipinski's rules that usually applies to compounds that can be administered orally. 
Therefore, one of the limitations of these compounds will probably be the route of their 
administration. The findings suggest that the new derivatives of imidazole and carbazole had the 
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